Gaetano’s Story: From Industrial Pharmacy in Rome to Molecular AI with Neovarsity
Gaetano earned his degree in Industrial Pharmacy from the University of Rome Tor Vergata and is now studying Molecular AI to advance his career in pharmaceutical R&D.
7 min read
September 10th, 2025
Last updated: September 10th, 2025
Introduction
Originally from Italy, Gaetano began his academic journey in pharmacy, gaining a strong foundation in drug dispensation and patient care within a regulated healthcare environment.
While working in the pharmacy settings, he developed an interest in personalized medicine, especially in understanding how to select the most appropriate drug for each patient by evaluating interactions, contraindications and therapeutic outcomes. This hands-on experience sharpened his interest in precision therapeutics and sparked a deeper question:
“Could artificial intelligence (AI) accelerate the design of safer and more effective drugs tailored to individual needs?”
This curiosity made him shift his research towards computational approaches and molecular innovation.
Gaetano’s Learning Curve and Research Journey
Gaetano earned his degree in Industrial Pharmacy from the University of Rome Tor Vergata , a program designed to integrate pharmaceutical sciences with industrial and research-oriented applications. From the beginning, his academic path was shaped by a strong multidisciplinary approach that combined chemistry, biology, pharmacology, and formulation science, giving him a comprehensive understanding of how drugs are conceived, developed, and optimized.
Through his coursework in pharmaceutical chemistry, he explored the intricate relationship between molecular structure and biological activity. This fascination with structure-activity relationships (SAR) laid the foundation for his long-standing curiosity about how subtle changes at the atomic level can influence therapeutic outcomes. His studies in chemotherapy and pharmacology further reinforced this interest, as he examined mechanisms of action, therapeutic benefits, and the often delicate balance between efficacy and safety in drug design.
Further training in pharmaceutical technology gave him insight into rheology and the behavior of materials in dosage forms, while pathology taught him to connect clinical signs with underlying disease mechanisms.
His studies in spectroscopy and mass spectrometry added a technical dimension, covering IR and NMR concepts such as Fourier transform, free induction decay, and Larmor frequency. These experiences sharpened his analytical skills and nurtured a lasting interest in molecular behavior under physical forces, now central to his learning in computational modeling.
In his final year, Gaetano synthesized his scientific training into a dissertation on the role of AI in drug discovery. He examined algorithms such as multilayer perceptrons, which identify a broader range of drug candidates than traditional methods; convolutional neural networks, capable of detecting complex molecular interaction patterns; random forests, which improve predictive power through ensemble learning; and recurrent neural networks, well-suited for modeling biological sequences and chemical reactions over time.
His analysis underscored both the opportunities and the challenges of this emerging field. While issues such as data quality and the need for specialized expertise remain significant, he concluded that AI is already accelerating compound screening, modeling diseases with unprecedented precision, and even offering tools to anticipate future pandemics.
“ The challenges of AI, like messy data or the need for skilled experts, don’t discourage me. Rather, they remind me that this is still a young field, and that there’s room to contribute.”
Exploring Molecular AI with Neovarsity’s Specialization Course
To pursue his passion in bridging molecules and computation, Gaetano enrolled in Neovarsity’s Molecular AI specialization, immersing himself in cheminformatics, Python programming, and molecular modeling.
“ Coding was a real challenge for me in the beginning, but with persistence and guidance from the mentor, I was able to push through. Along the way, I learned the importance of writing clean, modular Python code for analyzing chemical structures. This is a skill that now shapes my entire approach to data-driven drug design.”
Deepening His Knowledge of Molecular AI
Through Neovarsity’s Molecular AI specialization, Gaetano honed the technical skills central to modern drug discovery. He gained hands-on experience with RDKit, using it for molecular manipulation, descriptor calculation, and fingerprinting, and with KNIME, applying it to build data pipelines, run QSAR models, and perform virtual screening.
“One of the highlights of my learning was implementing chemical similarity calculations in both RDKit and KNIME. It pushed me to adapt quickly and gave me confidence in handling different computational tools,” he says.
As he advanced, Gaetano developed a sharper understanding of how atomic spatial arrangements and electronic properties influence biological activity. Computational methods allowed him to study these relationships at scale, revealing patterns and insights that traditional approaches could not capture.
Motivation and Future Goals
Looking ahead, Gaetano’s aspirations are ambitious yet focused.
He aims to collaborate with multidisciplinary teams to identify and optimize scaffolds, design selective molecules, and model atom-level interactions to improve binding and efficacy. He envisions building neural network models capable of predicting molecular behavior from both structural and sequential data.
As he reflects on this journey, his words capture his mindset best: “From here on, my primary goal is to keep exploring computational chemistry in all its forms. It’s the unknown that drives me the most.”
Closing Thoughts With a strong foundation in pharmaceutical sciences and growing expertise in cheminformatics and AI, Gaetano is well-prepared to contribute to the evolving field of computational drug discovery.
His time at Neovarsity has not only provided him with advanced technical skills but also fostered a visionary mindset, one focused on designing better drugs, improving patient outcomes, and pushing the boundaries of pharmaceutical research.
Note for Recruiters
Gaetano is now looking to translate his knowledge into impact. He is actively exploring opportunities in:
- Cheminformatics
- AI-driven drug design
- Pharmaceutical R&D
He brings to the table a unique background in Industrial pharmacy, distinct from traditional pharmacy tracks. Paired with hands-on experience in Python, RDKit, KNIME, and molecular modeling along with the motivation to work at the intersection of chemistry, AI, and innovation, he aims to bridge computational methods with real-world therapeutic development.
Open to remote, hybrid, or on-site roles across Europe, Gaetano welcomes collaborations with companies, startups, and research teams driving the future of small-molecule therapeutics.
Feel free to connect via LinkedIn or contact Neovarsity support for more details.
About Molecular AI Specialization
Neovarsity’s Molecular AI Specialization is a tailored curriculum designed to empower individuals with the expertise to leverage machine learning and artificial intelligence in small-molecule drug discovery. This specialization bridges the gap between conventional pharmaceutical research and cutting-edge computational drug design.
Interested in joining our Molecular AI Specialization like Gaetano? Contact us for personalized counseling. Initiate an online chat on the course page or contact us at [email protected]. .
Explore the experiences of learners who have embarked on the Molecular AI Specialization journey at Neovarsity.
Read here.
Neovarsity is a Berlin-based deep tech skills platform. We build industry-driven, cohort-based programs in collaboration with world-class experts to prepare talent and teams to solve problems in areas with real-world impact.
Follow us on LinkedIn and join the conversation using #FutureThroughDeepTech.